Gunnar Juliusson

9PUBLICATIONS
70CO-AUTHORS
Regenerative medicine (incl. stem cells)Haematological tumoursSocial epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 03, 2025
Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial.

Tim R Mocking, Lukas H Haaksma, Tom Reuvekamp

|Mar 29, 2025
Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia.

Vinod Pullarkat, Keith W Pratz, Hartmut Döhner

|Jan 23, 2025
Income and education affect prognosis and treatment in symptomatic myeloma : A population-based study on 8672 multiple myeloma patients diagnosed 2008-2021 from the Swedish myeloma registry.

Gunnar Larfors, Kristina Carlson, Christopher Day

|Jun 11, 2024
Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data.

Christoph Abé, Jaana Keto, Mathias Lilja

|Jun 08, 2024
Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms.

Michael Grever, Leslie Andritsos, Mirela Anghelina

|Mar 14, 2024
Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century.

Kari Hemminki, Frantisek Zitricky, Asta Försti

Pageof 2

Frequent Collaborators

3 joint publications

Vladimir Lj Lazarevic

3 joint publications

Bjørn T Gjertsen

2 joint publications

Bob Löwenberg

2 joint publications

Thomas Pabst